Paper26317854
Role of Marine Natural Products in the Genesis of Antiviral Agents.
Gogineni V and 2 others. Chem Rev, 2015. Cited by 77 papers, by iCite.
Cite this record
ConductScience Library. Role of Marine Natural Products in the Genesis of Antiviral Agents. Papers, record 26317854. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26317854
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Aquatic Organisms | Major topic |
| Biological Products | Major topic |
| Acquired Immunodeficiency Syndrome | |
| Dengue | |
| Ebolavirus | |
| HIV Infections | |
| Hepatitis B | |
| Herpes Zoster | |
| Humans | |
| Papillomaviridae | |
| Pneumonia, Viral | |
| Respiratory Syncytial Viruses | |
| Virus Replication |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 AI050409 | NIAID NIH HHS | United States | P30AI050409 | PubMed and NIH | NIH RePORTER |
| R01 MH100999 | NIMH NIH HHS | United States | R01MH100999 | PubMed and NIH | NIH RePORTER |
| 1R01-MH-100999 | NIMH NIH HHS | United States | R01MH100999 | PubMed and NIH | NIH RePORTER |
| 5P30-AI-50409 | NIAID NIH HHS | United States | P30AI050409 | PubMed and NIH | NIH RePORTER |
| 1R01AT007318 | NCCIH NIH HHS | United States | R01AT007318 | PubMed and NIH | NIH RePORTER |
| R01 AT007318 | NCCIH NIH HHS | United States | R01AT007318 | PubMed and NIH | NIH RePORTER |
References298
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24320933 | Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection. | J Med Chem | 2014 | https://conductscience.org/library/papers/24320933 | PubMed |
| 2 | 10821714 | Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors. | J Med Chem | 2000 | https://conductscience.org/library/papers/10821714 | PubMed |
| 3 | 21867732 | In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus. | Antiviral Res | 2011 | https://conductscience.org/library/papers/21867732 | PubMed |
| 4 | 20337497 | Anti-infective discorhabdins from a deep-water alaskan sponge of the genus Latrunculia. | J Nat Prod | 2010 | https://conductscience.org/library/papers/20337497 | PubMed |
| 5 | 17321313 | Evolution of China's response to HIV/AIDS. | Lancet | 2007 | https://conductscience.org/library/papers/17321313 | PubMed |
| 6 | 17804167 | Chemical transformation and biological studies of marine sesquiterpene (S)-(+)-curcuphenol and its analogs. | Biochim Biophys Acta | 2007 | https://conductscience.org/library/papers/17804167 | PubMed |
| 7 | 18049474 | The design of drugs for HIV and HCV. | Nat Rev Drug Discov | 2007 | https://conductscience.org/library/papers/18049474 | PubMed |
| 8 | 12002998 | Stachyflin and acetylstachyflin, novel anti-influenza A virus substances, produced by Stachybotrys sp. RF-7260. II. Synthesis and preliminary structure-activity relationships of stachyflin derivatives. | J Antibiot (Tokyo) | 2002 | https://conductscience.org/library/papers/12002998 | PubMed |
| 9 | 12667250 | New antiretroviral drugs. | Clin Microbiol Infect | 2003 | https://conductscience.org/library/papers/12667250 | PubMed |
| 10 | 7935654 | Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. | N Engl J Med | 1994 | https://conductscience.org/library/papers/7935654 | PubMed |
| 11 | 9607823 | Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. | J Infect Dis | 1998 | https://conductscience.org/library/papers/9607823 | PubMed |
| 12 | 15855531 | Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/15855531 | PubMed |
| 13 | 8057471 | Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. | J Virol | 1994 | https://conductscience.org/library/papers/8057471 | PubMed |
| 14 | 9918775 | Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins. | Biochem Biophys Res Commun | 1998 | https://conductscience.org/library/papers/9918775 | PubMed |
| 15 | 8709112 | Structure--activity relationships of the didemnins. | J Med Chem | 1996 | https://conductscience.org/library/papers/8709112 | PubMed |
| 16 | 9648250 | Regioselective syntheses of sulfated polysaccharides: specific anti-HIV-1 activity of novel chitin sulfates. | Carbohydr Res | 1998 | https://conductscience.org/library/papers/9648250 | PubMed |
| 17 | 1696911 | The inhibition of human immunodeficiency virus type 1 reverse transcriptase by avarol and avarone derivatives. | FEBS Lett | 1990 | https://conductscience.org/library/papers/1696911 | PubMed |
| 18 | 23678167 | Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. | J Virol | 2013 | https://conductscience.org/library/papers/23678167 | PubMed |
| 19 | 1320646 | Comparative biology of latent varicella-zoster virus and herpes simplex virus infections. | J Infect Dis | 1992 | https://conductscience.org/library/papers/1320646 | PubMed |
| 20 | 19000820 | Mechanism for coordinated RNA packaging and genome replication by rotavirus polymerase VP1. | Structure | 2008 | https://conductscience.org/library/papers/19000820 | PubMed |
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42646492 | Marine-Derived Natural Products Against Flaviviruses: Mechanisms, Evidence, and Future Directions. | Mar Drugs | 2026 | https://conductscience.org/library/papers/42646492 | PubMed |
| 41983768 | Febrifugine dihydrochloride restricts porcine epidemic diarrhea virus replication by modulating the IGF1R-driven PI3K/AKT-apoptosis axis. | J Virol | 2026 | https://conductscience.org/library/papers/41983768 | PubMed |
| 41588766 | Unraveling the Multifunctional Therapeutic Potential of Topsentin: A Marine-derived Versatile Scaffold. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/41588766 | PubMed |
| 41140501 | Acid-catalysed rearrangement of acyl groups: synthesis of β-d-gluco aminocyclopentitols and carbanucleoside derivatives. | RSC Adv | 2025 | https://conductscience.org/library/papers/41140501 | PubMed |
| 41034321 | Purine-based chemical probe with HOMO switching for intracellular detection of mercury ions. | Sci Rep | 2025 | https://conductscience.org/library/papers/41034321 | PubMed |
| 39921221 | Bird's eye view of natural products for the development of new anti-HIV agents: Understanding from a therapeutic viewpoint. | Animal Model Exp Med | 2025 | https://conductscience.org/library/papers/39921221 | PubMed |
| 39301783 | Uncovering the Potent Antiviral Activity of the Sesterterpenoids from the Sponge Ircinia Felix Against Human Adenoviruses: from the Natural Source to the Total Synthesis. | Chemistry | 2024 | https://conductscience.org/library/papers/39301783 | PubMed |
| 38474490 | A Marine Natural Product, Harzianopyridone, as an Anti-ZIKV Agent by Targeting RNA-Dependent RNA Polymerase. | Molecules | 2024 | https://conductscience.org/library/papers/38474490 | PubMed |
| 38326489 | Identification and characterization of a marine bacterium extract from Mameliella sp. M20D2D8 with antiviral effects against influenza A and B viruses. | Arch Virol | 2024 | https://conductscience.org/library/papers/38326489 | PubMed |
| 38116085 | Chaga mushroom: a super-fungus with countless facets and untapped potential. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38116085 | PubMed |
| 37766233 | Structural and Synthetic Aspects of Small Ring Oxa- and Aza-Heterocyclic Ring Systems as Antiviral Activities. | Viruses | 2023 | https://conductscience.org/library/papers/37766233 | PubMed |
| 37629123 | Comparative Transcriptome Profiling Reveals Two WRKY Transcription Factors Positively Regulating Polysaccharide Biosynthesis in Polygonatum cyrtonema. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37629123 | PubMed |
| 37155475 | In-Silico Approaches for the Screening and Discovery of Broad-Spectrum Marine Natural Product Antiviral Agents Against Coronaviruses. | Infect Drug Resist | 2023 | https://conductscience.org/library/papers/37155475 | PubMed |
| 36680290 | Chetomin, a SARS-CoV-2 3C-like Protease (3CLpro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis. | Viruses | 2023 | https://conductscience.org/library/papers/36680290 | PubMed |
| 36366550 | Antiviral Potential of Natural Resources against Influenza Virus Infections. | Viruses | 2022 | https://conductscience.org/library/papers/36366550 | PubMed |
| 35955547 | A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35955547 | PubMed |
| 35736176 | The Development of the Bengamides as New Antibiotics against Drug-Resistant Bacteria. | Mar Drugs | 2022 | https://conductscience.org/library/papers/35736176 | PubMed |
| 35628408 | Antiretroviral Therapy-Induced Dysregulation of Gene Expression and Lipid Metabolism in HIV+ Patients: Beneficial Role of Antioxidant Phytochemicals. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628408 | PubMed |
| 35565968 | Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses. | Molecules | 2022 | https://conductscience.org/library/papers/35565968 | PubMed |
| 35425294 | NS3 helicase inhibitory potential of the marine sponge Spongia irregularis. | RSC Adv | 2022 | https://conductscience.org/library/papers/35425294 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26317854
GET https://conductscience.org/api/papers/v1/26317854/references?page=2